FDA narrows indications for Wingspan intracranial stent system

Stryker’s Wingspan stent is used to open narrowed arteries within the brain in patients who are experiencing repeated strokes. This is a serious condition with few treatment options. The device was originally approved by FDA in 2005 as a Humanitarian Use Device (HDE), a category for rare conditions. FDA has changed the labeling of this … Read more

New AHA/ASA scientific advisory on stroke prevention in atrial fibrillation

The American Heart Association / American Stroke Association has published a scientific advisory which includes new oral anticoagulants to prevent stroke in patients with atrial fibrillation. For many years, the only oral anticoagulant available has been warfarin (Coumadin). Alternatives have now been introduced. Dabigatran (Pradaxa) was approved by FDA in October 2010, followed by rivaroxaban … Read more